Diseases associated with hidranitis suppurativa: Part 2 of a series on hidradenitis

Dermatology Online Journal

Volumn 19, Issue 6, 2013, Pages

  Scheinfeld, Noah ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Hidradenitis suppurativa

Indexed keywords

ADALIMUMAB; AMYLOID A PROTEIN; ANTIBIOTIC AGENT; AZATHIOPRINE; BENZOYL PEROXIDE; BISPHOSPHONIC ACID DERIVATIVE; BUSERELIN; C REACTIVE PROTEIN; CYCLOSPORIN; DOXYCYCLINE; ETANERCEPT; ETHINYLESTRADIOL; ETYNODIOL; INFLIXIMAB; ISOTRETINOIN; LEVONORGESTREL; LITHIUM SALT; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; RAPAMYCIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; USTEKINUMAB; VEMURAFENIB;

ACNE CONGLOBATA; ACNE VULGARIS; ACROMEGALY; AMYLOIDOSIS; ANEMIA; ANKYLOSING SPONDYLITIS; ANTIGEN ANTIBODY COMPLEX; ANUS FISTULA; BAZEX DUPRE CHRISTOL SYNDROME; BEHCET DISEASE; COLLAGEN DISEASE; COMPLEX REGIONAL PAIN SYNDROME; CONDYLOMA; CONGENITAL PACHYONYCHIA; CORNEA RODENT ULCER; CROHN DISEASE; DACTYLITIS; DEPRESSION; DISEASE ASSOCIATION; DISSECTING CELLULITIS; DOWLING DEGOS DISEASE; DOWN SYNDROME; DRUG ERUPTION; ENTERITIS; EROSIVE ARTHROPATHY; ERYTHEMA NODOSUM; ERYTHROCYTE SEDIMENTATION RATE; FOLLICULITIS; FOX FORDYCE DISEASE; GRANULOMATOUS LOBULAR MASTITIS; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERKERATOSIS; HYPERTENSION; HYPOPROTEINEMIA; INTERSTITIAL KERATITIS; INTERSTITIAL NEPHRITIS; KERATOACANTHOMA; LIVER CANCER; MAMMAR DUCT FISTULA; MELANOMA; METABOLIC SYNDROME X; MONARTHRITIS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE EPIDERMAL CYSTS; NEVUS; OBESITY; OSTEOMYELITIS; PAIN; PAPA SYNDROME; PAPULE; PASH SYNDROME; PATHOLOGY; PILONIDAL SINUS; PITYRIASIS RUBRA PILARIS; POLYARTHRITIS; POLYCLONAL IMMUNOGLOBULINEMIA; PROTEINURIA; PRURTIS ANI; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULE; PYODERMA FISTULANS SIGNIFICA; PYODERMA GANGRENOSUM; PYODERMA VEGETANS; REACTIVE INFLAMMATORY ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SACROILIITIS; SAPHO SYNDROME; SCALP FOLLICULITIS; SERONEGATIVE INFLAMMATORY ARTHRITIS; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; STEATOCYSTOMA MULTIPLEX; SUPPURATIVE HIDRADENITIS; SYNDROME KID; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; ACQUIRED HYPEROSTOSIS SYNDROME; ARTHRITIS; AUTOIMMUNE DISEASES; CELLULITIS; CHEMICALLY INDUCED; CHRONIC PAIN; COMORBIDITY; COMPLICATION; DEPRESSIVE DISORDER; HAIR FOLLICLE; HIDRADENITIS SUPPURATIVA; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; KERATOSIS; STAPHYLOCOCCAL SKIN INFECTION; AUTOIMMUNE DISEASE; CHEMICALLY INDUCED DISORDER; INFLAMMATORY BOWEL DISEASE;

ACNE VULGARIS; ACQUIRED HYPEROSTOSIS SYNDROME; ARTHRITIS; AUTOIMMUNE DISEASES; CELLULITIS; CHRONIC PAIN; COMORBIDITY; DEPRESSIVE DISORDER; HAIR FOLLICLE; HIDRADENITIS SUPPURATIVA; INFLAMMATORY BOWEL DISEASES; KERATOSIS; METABOLIC SYNDROME X; OBESITY; PILONIDAL SINUS; PYODERMA GANGRENOSUM; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 84879288267     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (311)

1. Scheinfeld N. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2013 April;14(4):1.
2. Smith HS, Chao JD, Teitelbaum J. Painful hidradenitis suppurativa. Clin J Pain 2010;26:435-44. [PMID: 20473053]
3. Mortimer PS, Dawber RP, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):245-8. [PMID: 2936421]
4. Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009 Sep;23(9):985-98 [PMID: 19682181]
5. Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013 Jan;133(1):97-103. [PMID: 22931916]
6. Henderson MD, Abboud J, Cogan CM, Poisson LM, Eide MJ, Shwayder TA, Lim HW. Skin-of-color epidemiology: a report of the most common skin conditions by race. Pediatr Dermatol. 2012 Sep-Oct;29(5):584-589. [PMID: 22639933]
7. Perkins AC, Maglione J, Hillebrand GG, Miyamoto K, Kimball AB. Acne vulgaris in women: prevalence across the life span. J Womens Health (Larchmt). 2012 Feb;21(2):223-30. [PMID: 22171979]
8. Jemec G.B.E., Revuz J., Leyden J.J.: Hidradenitis suppurativa. Springer-Verlag. Berlin-Heidelberg-New York 2006.
9. Husein-ElAhmed H, Fernandez-Pugnaire MA, Ruiz-Carrascosa JC. Severe hidradenitis suppurative in an HIV-positive male: use of multiple treatment modalities, including tumor necrosis factor blockade. AIDS Patient Care STDS. 2001 Sep;25(9):507-8. [PMID: 21851262]
10. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):191-4. [PMID: 8708018]
11. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013 Mar;168(3):474-85. [PMID: 23210645]
12. Halvorsen JA, Vleugels RA, Bjertness E, Lien L. A population-based study of acne and body mass index in adolescents. Arch Dermatol. 2012 Jan;148(1):131-2. [PMID: 22250253]
13. Shen Y, Wang T, Zhou C, Wang X, Ding X, Tian S, Liu Y, Peng G, Xue S, Zhou J, Wang R, Meng X, Pei G, Bai Y, Liu Q, Li H, Zhang J. Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities. Acta Derm Venereol. 2012 Jan;92(1):40-4. [PMID: 21710106]
14. Chalmers RJ, Ead RD, Beck MH, Dewis P, Anderson DC. Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J (Clin Res Ed). 1983 Nov 5;287(6402):1346-7. [PMID: 6227362]
15. Rosner IA, Richter DE, Huettner TL, Kuffner GH, Wisnieski JJ, Burg CG. Spondyloarthropathy associated with hidradenitis suppurative and acne conglobata. Ann Intern Med. 1982 Oct;97(4):520-5. [PMID: 6214980]
16. Steinhoff JP, Cilursu A, Falasca GF, Guzman L, Reginato AJ. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol. 2002 Feb;8(1):13-22. [PMID: 17039195]
17. Kierland RR. Unusual pyodermas (hidrosadenitis suppurativa, acne conglobata, dissecting cellulitis of the scalp). Minn Med. 1951 Apr;34(4):319-25. [PMID: 14826630]
18. Velasco AL, Dunlap WW. Pilonidal disease and hidradenitis. Surg Clin North Am. 2009 Jun;89(3):689-701. [PMID 19465205]
19. von Laffert M, Stadie V, Ulrich J, Marsch WC, Wohlrab J. Morphology of pilonidal sinus disease: some evidence of its being a unilocalized type of hidradenitis suppurativa. Dermatology. 2011;223(4):349-55. [PMID: 22269798]
20. Thein M, Hogarth MB, Acland K. Seronegative arthritis associated with the follicular occlusion triad. Clin Exp Dermatol. 2004 Sep;29(5):5502. [PMID: 15347350]
21. Zisova L, Sakakushev B. Acne tetrad in a family. Folia Med (Plovdiv). 1994;36(4):517. [PMID: 8698287]
22. Leybishkis B, Fasseas P, Ryan KF, Roy R. Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy. Am J Med Sci. 2001 Mar;321(3):1957. [PMID: 11269796]
23. Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis. 1999 Aug;64(2):8790. [PMID: 10467498]
24. Shenefelt PD. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Cutis. 1996 May;57(5):3159. [PMID: 8726710]
25. Rosner IA, Burg CG, Wisnieski JJ, Schacter BZ, Richter DE. The clinical spectrum of the arthropathy associated wit hidradenitis suppurativa and acne conglobata. J Rheumatol. 1993 Apr;20(4):6847. [PMID: 8496865]
26. Saal JG, Wojatschek C, Rautenstrauch H. HLA-B27-negative sacroiliitis as a complication of inflammatory forms of acne: case reports and review of the literature. Z Rheumatol. 1988 Nov-Dec;47(6):405-12. [PMID: 2977039]
27. Vasey FB, Fenske NA, Clement GB, Bridgeford PH, Germain BF, Espinoza LR. Immunological studies of the arthritis of acne conglobata and hidradenitis suppurativa. Clin Exp Rheumatol. 1984 Oct-Dec;2(4):30911. [PMID: 6241861]
28. Rosner IA, Richter DE, Huettner TL, Kuffner GH, Wisnieski JJ, Burg CG. Spondyloarthropathy associated with hidradenitis suppurative and acne conglobata. Ann Intern Med. 1982 Oct;97(4):5205. [PMID: 6214980]
29. Deschamps ME, Payet S, Tournadre A, Soubrier M, Souteyrand P, D'Incan M. Efficacy of infliximab in the treatment of follicular occlusion triad. Ann Dermatol Venereol. 2010 AugSep;137(89):54650. [PMID: 20804900]
30. Chicarilli ZN. Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp. Ann Plast Surg 1987;18(3):230-7. [PMID:2954503]
31. Olafsson S, Khan MA. Musculoskeletal features of acne, hidradenitis suppurativa, and dissecting cellulitis of the scalp. Rheum Dis Clin North Am. 1992 Feb;18(1):215-24. [PMID: 1532858]
32. Goldsmith PC, Dowd PM. Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J R Soc Med. 1993 Dec;86(12):72930. [PMID: 8308815]
33. Saraceno R, Teoli M, Casciello C, Chimenti S. Methyl aminolaevulinate photodynamic therapy for the treatment of hidradenitis suppurativa and pilonidal cysts. Photodermatol Photoimmunol Photomed. 2009 Jun;25(3):1645. [PMID: 19438999]
34. Velasco AL, Dunlap WW. Pilonidal disease and hidradenitis. Surg Clin North Am. 2009 Jun;89(3):689-701. [PMID: 19465205]
35. Breuninger H. Treatment of pilonidal sinus and acne inversa. Hautarzt. 2004 Mar;55(3):2548. [PMID: 15029431]
36. Olafsson S, Khan MA. Musculoskeletal features of acne, hidradenitis suppurativa, and dissecting cellulitis of the scalp. Rheum Dis Clin North Am. 1992 Feb;18(1):21524. [PMID: 1532858]
37. Jain V, Jain A. Use of lasers for the management of refractory cases of hidradenitis suppurativa and pilonidal sinus. J Cutan Aesthet Surg. 2012 Jul;5(3):1902. [PMID: 23112515]
38. Poli F, Wolkenstein P, Revuz J. Back and face involvement in hidradenitis suppurativa. Dermatology. 2010;221(2):13741. [PMID: 20606396]
39. Dufresne RG Jr, Ratz JL, Bergfeld WF, Roenigk RK. Squamous cell carcinoma arising from the follicular occlusion triad. J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):4757. [PMID: 8784291]
40. Meyers SW, Bercovitch L, Polley K, Taira J, DeCamp N, Mahalingam M, Grillone G, Grande D. Massive exophytic abscesses and fibrotic masses of the chin: a variant of the follicular occlusion triad. J Am Acad Dermatol. 2003 May;48(5 Suppl):S4750. [PMID: 12734472]
41. Koopmann MD, Ketterings C. Suppurative hidradenitis and acne conglobata. Ned Tijdschr Geneeskd. 1982 Mar 6;126(10):4114. [PMID: 6461830]
42. Hidradenitis Suppurativa Foundation (HSF), www.hs-foundation.org.
43. Bazex A, Salvador R, Dupre A, Parant M, Christol B, Corraze J. Acne pustulosa conglobata generalis with keloid transformation of the tegument: congenital hypoalgia to pain; Psychopathic personality (murder). Psychosomatic study. Bull Soc Fr Dermatol Syphiligr. 1963 Jul-Aug;70:444-5.
44. Prasad PV, Kaviarasan PK, Joseph JM, Madhuri S, Viswanathan P. Familial acne inversa with acne conglobata in three generations. Indian J Dermatol Venereol Leprol. 2008 May Jun;74(3):2835. [PMID: 18583816]
45. O'Leary PA, et al: Acne conglobata, pyoderma, and hidradenitis suppurativa. Arch Dermatol Syph 47:725, 1943.
46. Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010 Jan;2(1):9-16. [PMID: 21547142]
47. Sivakumaran S, Meyer P, Burrows NP. Dissecting folliculitis of the scalp with marginal keratitis. Clin Exp Dermatol 2001 Sep;26(6):4902. [PMID: 11678871]
48. Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J. 2003 Feb;9(1):8. [PMID: 12639466]
49. Brǎnişteanu DE, Molodoi A, Ciobanu D, Bǎdescu A, Stoica LE, Brǎnişteanu D, Tolea I. Rom J. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp. Morphol Embryol. 2009;50(4):719-24. [PMID: 19942972]
50. Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobat with oral zinc. Br J Dermatol 1999;141(6): 1137-8.
51. Navarini AA, et al. 3 cases of dissecting cellulitis of the scalp treated with adalimumab: control of inflammation within residual structural disease. Arch Dermatol 2010;146:517 [PubMed]
52. Wollina U, Gemmeke A, Koch A. Dissecting Cellulitis of the Scalp Responding to Intravenous Tumor Necrosis Factor-alpha Antagonist. J Clin Aesthet Dermatol. 2012 Apr;5(4):36-9. [PMID: 22708007]
53. Brandt HR, Malheiros AP, Teixeira MG, Machado MC. Perifolliculitis capitis abscedens et suffodiens successfully controlled with infliximab. Br J Dermatol. 2008 Aug;159(2):506-7. [PMID: 18547307]
54. Prasad SC, Bygum A. Successful Treatment with Alitretinoin of Dissecting Cellulitis of the Scalp in Keratitis-Ichthyosis-Deafness Syndrome. Acta Derm Venereol. 2012 Nov 13. [PMID: 23150172]
55. Scerri L, et al. Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol 1996;134:1105 [PubMed]
56. Karpouzis A et al. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin. Eu J Dermatol 2003;13:192 [PubMed]
57. Onderdijk AJ, Boer J. Successful treatment of dissecting cellulitis with ciprofloxacin. Clin Exp Dermatol. 2009 Oct;34(7):e507. [PMID: 19747334]
58. Williams CN, et al. Dissecting cellulitis of the scalp. Plast Reconstr Surg 1986;77:378 [PubMed]
59. Bellew SG, et al. Successful treatment of recalcitrant dissecting cellulitis of the scalp with complete scalp excision and split-thickness skin graft. Dermat Surg 2003;29:1068 [PubMed]
60. Arneja JS, Vashi CN, Gursel E, Lelli JL. Management of fulminant dissecting cellulitis of the scalp in the pediatric population: Case report and literature review. Can J Plast Surg. 2007 Winter;15(4):211-4. [PMID: 19554179] [PubMed]
61. McMullan FH, et al. Perifolliculitis capitis abscedens et suffodiens: its successful treatment with X ray epilation. Arc Dermat 1956; 73: 256 [PubMed]
62. Chinnaiyan P, et al. Modern external beam radiation therapy for refractory dissecting cellulitis of the scalp. Br J Dermatol 2005;152:777 [PubMed]
63. Krasner BD, et al. Dissecting cellulitis treated with the long-pulsed Nd: YAG laser. Derm Surg 2006;32:1039 [PubMed]
64. Curry SS, Gaither DH, King LE Jr. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp, A case report and review of secondary squamous cell carcinomas. J Amer Acad of Dermatol 1981;6:673-8. [PMID: 7240474]
65. Salim A, David J, Holder J. Dissecting cellulitis of the scalp with associated spondylarthropathy: case report and review. J Eur Acad Dermatol Venereol. 2003 Nov;17(6):689-91. [PMID: 14761139]
66. Ongchi DR, Fleming MG, Harris CA. Sternocostoclavicular hyperostosis: two cases with differing dermatologic syndromes. J Rheumatol. 1990 Oct;17(10):1415-8. [PMID: 2254905]
67. Nyquist GG, Mumm C, Grau R, Crowson AN, Shurman DL, Benedetto P, Allen P, Lovelace K, Smith DW, Frieden Hybarger CP, Richard G. Malignant proliferating pilar tumors arising in KID syndrome: a report of two patients. Am J Med Genet A. 2007 Apr 1;143(7):73441. [PMID: 17330861]
68. Ehrenreich EW. Perifolliculitis capitis abscedens et suffodiens. Interstitial keratitis. AMA Arch Derm Syphilol. 1953 Dec;68(6):744-6. [PMID: 13103820]
69. Wasserman E. Perifolliculitis capitis abscedens et suffodiens with rheumatoid arthritis; report of a case. AMA Arch Derm Syphilol. 1951 Dec;64(6):787-9. [PMID: 14867922]
70. Grech I, Giatrakou S, Damoraki G, Pistiki A, Kaldrimidis P, Giamarellos-Bourboulis EJ, Stavrianeas N. Single nucleotide polymorphisms of toll-like receptor-4 protect against acne conglobata. J Eur Acad Dermatol Venereol. 2012 Dec;26(12):1538-43. [PMID: 22085193]
71. Acne conglobata of the buttocks aggravated by mechanical and environmental factors. Darley CR. Clin Exp Dermatol. 1990 Nov;15(6):462-3. [PMID: 2149087]
72. Aithal V, Appaih P. Lithium induced hidradenitis suppurativa and acne conglobata. Indian J Dermatol Venereol Leprol. 2004 Sep-Oct;70(5):3079. [PMID: 17642646]
73. Misery L, Feton-Danou N, Consoli A, Chastaing M, Consoli S, Schollhammer M; pour Le Groupe psychodermatologie de Société française de dermatologie. Isotretinoin and adolescent depression. Ann Dermatol Venereol. 2012 Feb;139(2):118-23. [PMID: 22325750]
74. Vega J, Sánchez-Velicia L, Efficacy of etanercept in the treatment of acne conglobata Pozo T. Actas Dermosifiliogr. 2010 Jul;101(6):553-4. [PMID: 20738977]
75. Shirakawa M, Uramoto K, Harada FA. Treatment of acne conglobata with infliximab. J Am Acad Dermatol. 2006 Aug;55(2):344-6. [PMID: 16844527]
76. Myers JN, Mason AR, Gillespie LK, Salkey KS. Treatment of acne conglobata with modern external beam radiation. J Am Acad Dermatol. 2010 May;62(5):861-3. [PMID: 1966525]
77. Hasegawa T, Matsukura T, Hirasawa Y, Otsuki A, Tsuchihashi H, Niwa Y, Okuma K, Ogawa H, Ikeda S. Acne conglobata successfully treated by fractional laser after CO laser abrasion of cysts combined with topical tretinoin. J Dermatol. 2009 Feb;36(2):118-9. [PMID: 19284461]
78. Hasegawa T, Matsukura T, Suga Y, Muramatsu S, Mizuno Y, Tsuchihashi H, Haruna K, Ogawa H, Ikeda S. Case of acne conglobata successfully treated by CO(2) laser combined with topical tretinoin therapy. J Dermatol. 2007 Aug;34(8):58 [PMID: 17683393]
79. Jeong S, Lee CW. Acne conglobata: treatment with isotretinoin, colchicine, and cyclosporin as compared with surgical intervention. Clin Exp Dermatol. 1996 Nov;21(6):462-3. [PMID: 9167351]
80. Jeandel P, Prigent D, Chouc PY, Sulimovic H, Normand P. Enthesitic talalgia associated with calcaneal osteitis revealing rheumatism of acne conglobata. Ann Med Interne (Paris). 1991;142(5):387-8.
81. Whipp MJ, Harrington CI, Dundas S. Fatal squamous cell carcinoma associated with acne conglobata in a father and daughter. Br J Dermatol. 1987 Sep;117(3):389-92. [PMID: 2960372]
82. Ehrenfeld M, Samra Y, Kaplinsky N. Acne conglobata and arthritis: report of a case and review of the literature. Clin Rheumatol. 1986 Sep;5(3):407-9. [PMID: 2946511]
83. Bogas M, Afonso MC, Araújo D. Sacroileitis and acne conglobata: SAPHO Syndrome. Acta Reumatol Port. 2008 Jul-Sep;33(3):370-375. [PMID: 18846019]
84. Laber DA, Ravakhah K, Smith HR. HIV-associated pityriasis Acne conglobata associated with spondyloarthropathy and ankylosis of the wrists. J Clin Rheumatol. 1999 Jun;5(3):169-72. [PMID: 19078379]
85. Gutzmer R, Herbst RA, Kapp A, Weiss J. SAPHO syndrome. Case description of 3 patients with acne conglobata an osteoarticular symptoms. Hautarzt. 1997 Mar;48(3):186-90. [PMID: 9182090]
86. Gallo M, La Montagna G, Tirri G. Ankylosing spondylarthritis associated with acne conglobata. Rheumatol Int. 1989;9(2):91-3.
87. Knüchel M, Luderschmidt C. Osteonecrosis in acne conglobata. Z Hautkr. 1986 Aug 1;61(15):1092-8. [PMID: 2945329]
88. Beraneck L, Kaplan G, Benoist M, Bouchon JP, Prost A, Vassal JP, Kahn MF. Multiple hyperostosis with unilateral sacroiliitis. A new spondyloarthropathy. Presse Med. 1984 Sep 29;13(33):2001-4. [PMID: 6238296]
89. Manz B, Rytter M, Mittag M, Seidel W, Nenoff P. ANCA-positive vasculitis of the skin and kidneys associated with acne conglobata. Hautarzt. 2002 Nov;53(11):730-4. [PMID: 12402135]
90. Pérez-Villa F, Campistol JM, Ferrando J, Botey A. Renal amyloidosis secondary to acne conglobata. Int J Dermatol. 1989 Mar;28(2):132-3. [PMID: 2525536]
91. Hatron PY, Thomas P, Vandenbussche F, Gosselin B, Devulder B. Renal amylosis secondary to acne conglobata of the buttocks. Rapid development to renal insufficiency after surgical excision of the suppurative foci. Presse Med. 1983 Jan 15;12(2):107. [PMID: 6221317]
92. Shimomura Y, Nomoto S, Yamada S, Ito A, Ito K, Ito M. Chronic glomerulonephritis remarkably improved after surgery for acne conglobata of the buttocks. Br J Dermatol. 2001 Aug;145(2):363-4. [PMID: 11531818]
93. Naya MT, Soria C, Quereda C, Orte L, Romero R, Ortuño J. End-stage renal disease in a patient with amyloidosis secondary to acne conglobata. Nephron. 1991;57(1):109-10. [PMID: 1828540]
94. Birnkrant MJ, Papadopoulos AJ, Schwartz RA, Lambert WC. Pyoderma gangrenosum, acne conglobata, and IgA gammopathy. Int J Dermatol. 2003 Mar;42(3):213-6. [PMID: 12653919]
95. Velez A, Alcala J, Fernandez-Roldan JC. Pyoderma gangrenosum associated with acne conglobata. Clin Exp Dermatol. 1995 Nov;20(6):496-8. [PMID: 8857346]
96. Villaverde V, Munñoz-Fernández S, Hidalgo V, Cortés I, Fonseca A, Gijón-Baños J, Martín-Mola E. Acute anterior uveitis in a patient with sacroiliitis and acne conglobata. Rheumatology (Oxford). 1999 Aug;38(8):797-8. [PMID: 10501443]
97. Caravatti M, Wiesli P, Uebelhart D, Germann D, Welzl-Hinterkörner E, Schulthess G. Coincidence of Behçet's disease and SAPHO syndrome. Clin Rheumatol. 2002 Aug;21(4):324-7. [PMID: 12189464]
98. Miralles ES, Núñez M, De Las Heras ME, Pérez B, Moreno R, Ledo A. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol. 1995 Dec;133(6):990-3. [PMID: 854705771]
99. Wollenberg A, Wolff H, Jansen T, Schmid MH, Röcken M, Plewig G. Acne conglobata and Klinefelter's syndrome. Br J Dermatol. 1997 Mar;136(3):421-3. [PMID: 9115930]
100. Resnick SD, Murrell DF, Woosley JT. Pityriasis rubra pilaris, acne conglobata, and elongated follicular spines: an HIV-associated follicular syndrome? J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):283. [PMID: 8335758]
101. Martin AG, Weaver CC, Cockerell CJ, Berger TG. Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acne. Br J Dermatol. 1992 Jun;126(6):617-20. [PMID: 1535216]
102. González-López A, Velasco E, Pozo T, Del Villar A. Pitriasis rubra pilaris responsive to triple antiretroviral therapy. Br J Dermatol. 1999 May;140(5):931-4. [PMID: 10354036]
103. Jain K, Jain VK, Aggarwal K, Bansal A. Late onset isotretinoin resistant acne conglobata in a patient with acromegaly. Indian J Dermatol Venereol Leprol. 2008 Mar-Apr;74(2):139-41. [PMID: 18388374]
104. Wollenberg A, Wolff H, Jansen T, Schmid MH, Röcken M, Plewig G. Acne conglobata and Klinefelter's syndrome. Br J Dermatol. 1997 Mar;136(3):421-3. [PMID: 9115930]
105. Wollenberg A, Wolff H, Jansen T, Schmid MH, Röcken M, Plewig G. Acne conglobata and Klinefelter's syndrome. Br J Dermatol. 1997 Mar;136(3):421-3. [PMID: 9115930]
106. Boyd AS, Zemtsov A. A case of pyoderma vegetans and the follicular occlusion triad. J Dermatol. 1992 Jan;19(1):613. [PMID: 1534334]
107. Papadopoulos AJ, Schwartz RA, Kapila R, Samady JA, Ruszczak Z, Rao BK, Lambert WC. Pyoderma vegetans. J Cutan Med Surg. 2001 May-Jun;5(3):223-7. [PMID: 11685669]
108. Boyd AS, Zemtsov A. A case of pyoderma vegetans and the follicular occlusion triad. J Dermatol. 1992 Jan;19(1):613. [PMID: 1534334]
109. Williamson DM, Cunliffe WJ, Gatecliff M, Scott DG. Acute ulcerative acne conglobata (acne fulminans) with erythema nodosum. Clin Exp Dermatol. 1977 Dec;2(4):351-4. [PMID: 146578]
110. Lapins J, Ye W, Nyrén O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol. 2001 Jun;137(6):730-4. [PMID: 11405761]
111. Sion Vardy N, Osyntsov L, Cagnano E, Osyntsov A, Vardy D, Benharroch D. Unexpected location of pilonidal sinuses. Clin Exp Dermatol. 2009 Dec;34(8):e599601. [PMID: 19486057]
112. von Laffert M, Stadie V, Ulrich J, Marsch WC, Wohlrab J. Morphology of pilonidal sinus disease: some evidence of its being a unilocalized type of hidradenitis suppurativa. Dermatology. 2011;223(4):34955.
113. Kurokawa I, Nishijima S, Suzuki K, Kusumoto K, Sensaki H, Shikata N, Tsubura A. Cytokeratin expression in pilonidal sinus. Br J Dermatol. 2002 Mar;146(3):40913. [PMID: 11952540]
114. Slauf P, Antos F, Novák J, Benes J, Kálal J. Perianal pyoderma. Rozhl Chir. 1993 Oct;72(7):3313. [PMID: 8303482]
115. Hali F, Khadir K, Zouhair K, Benchikhi H, Azzouzi S. Suppurations of the perineal and gluteal region: An aetiological study of 60 cases. Ann Dermatol Venereol. 2010 Oct;137(10):591-6. [PMID: 20932437]
116. Fleischer I, Bryant D, Spiegel J, Christian R, Farraye FA. Peristomal hidradenitis suppurativa. J Wound Ostomy Continence Nurs. 1996 May;23(3):171-3. [PMID: 8845907]
117. Patient Care Committee of The Society for Surgery of the Alimentary Tract (SSAT). Treatment of perineal suppurative processes. J Gastrointest Surg. 2005 Mar;9(3):4579. [PMID: 15906475]
118. Chu EY, Kovarik CL, Lee RA. Lymphedematous verrucous changes simulating squamous cell carcinoma in longstanding hidradenitis suppurativa. Int J Dermatol. 2012 May 29. [PMID: 22640236]
119. Wittmann DH, Schein M, Seoane D, Aprahamian C, Komorowski RA, Georgakas K, Quebbeman EJ, Wallace JR, Condon RE. Pyoderma fistulans sinifica (fox den disease): a distinctive soft tissue infection. Clin Infect Dis. 1995 Jul;21(1):16270. [PMID: 7578725]
120. Krauspe C, Stelzner F. Pyodermia fistulans sinifica. On the clinical and histopathological changes in fistulous dermatitis with remarks on the relation to so called hidradenitis suppurativa and acne conglobata. Chirurg. 1962 Dec;33:5348 [PMID: 14035586]
121. Bassukas ID, Hundeiker M. Acne inversa (pyodermia fistulans sinifica) and smoking. J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):1029. [PMID: 9204079]
122. Heilberger P, Galli KH, Kreuzpaintner KH. Pyodermia sinifica fistulans with fatal outcome. Chirurg. 1994 Apr;65(4):395-8; discussion 398-9. [PMID: 8020365]
123. Stelzner F. Causes of pilonidal sinus and pyoderma fistulans sinifica. Langenbecks Arch Chir. 1984;362(2):105-18. [PMID: 6738258]
124. Eberle F, Adler G, Roth SL. Pyroderma fistulans sinifica associated with congenital alpha-1-antitrypsin deficiency. Hautarzt. 1980 Feb;31(2):100-4. [PMID: 6967474]
125. Haustein UF, Glander HJ, Bolck F.Pyodermia fistulans sinifica. Dermatol Monatsschr. 1979 Jun;165(6):418-24. [PMID: 499627]
126. Noster U, Schlosser GA, Jänner M. Giant condylomata acuminata (Buschke-Löwenstein) on the basis of pyoderma fistulans sinifica. Z Hautkr. 1977 Jan 15;52(2):45-9. [PMID: 835314]
127. Gahlen W, Grussendorf EI, Wienert V. Histological contribution to the clinical picture of so-called pyodermia fistulans sinifica as manifestation of severe acne (acne conglobata et sinifica). Z Hautkr. 1976 Aug 1;51(15):621-6. [PMID: 136819]
128. Noster U, Schlosser GA, Jänner M. Pyoderma fistulans sinifica. Z Hautkr. 1974 Mar 15;49(6):253-60. [PMID: 4836094]
129. Rill A. A modified method of therapy for pyodermia fistulans sinifica. Med Arh. 1965 Jul-Oct;19(4):69-74. [PMID: 5871076]
130. Penna V, Dowlatshahi S, Padron NT, Stark GB, Bannasch H. Surgery for Pyodermia fistulans sinifica to circumvent heart transplantation (Case Report). J Plast Reconstr Aesthet Surg. 2011 Jan;64(1):e12-6 [PMID: 20724234]
131. Steinert M, Keitel R, Schönfelder M. Is pyodermia fistulans sinifica of clinical importance? Langenbecks Arch Chir Suppl Kongressbd. 1997;114:556-8. German. [PMID: 9574206]
132. Margolis M, Schein M. Mega scrotum in pyoderma fistulans sinifica (fox den disease). Surg Infect (Larchmt). 2000 Summer;1(2):149-51. [PMID: 12594902]
133. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Bastuji-Garin S. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009 Jul;61(1):51-7. [PMID: 19406505]
134. Tanaka A, Goto Y, Iwade M, Uhara H, Okuyama R. Rapid progression of hidradenitis suppurativa in the lower leg of a patient with psoriasis vulgaris. Acta Derm Venereol. 2012 Jan;92(1):105-6. [PMID: 21879239]
135. Verma P, Chhabra N. A comment on rapid progression of hidradenitis suppurativa in the lower leg of a patient with psoriasis vulgaris. Acta Derm Venereol. 2012 Jul;92(4):447. [PMID: 22511235]
136. Weiner J, Lewis JE, Samitz MH. Hidradenitis suppurativa occurring on the leg. Cutis 1976;17:888-891. [PMID:1017265]
137. Baerveldt EM, Kappen JH, Thio HB, van Laar JA, van Hagen PM, Prens EP. Successful long term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa. Ann Rheum Dis. Ann Rheum Dis 2013;72:626-627 [PMID: 2314830]
138. Sharon VR, Garcia MS, Bagheri S, Goodarzi H, Yang C, Ono Y, Maverakis E. Management of recalcitrant hidradenitis suppurativa with ustekinumab. Acta Derm Venereol. 2012 May;92(3):320-1. [PMID: 22101775]
139. Nuño-González A, Dehesa L, Ricotti C, Kerdel F. Flexural or inverse psoriasis in a patient with hidradenitis suppurativa receiving treatment with infliximab. Actas Dermosifiliogr. 2012 Dec;103(10):9367. [PMID: 23149048]
140. Gori A, Rossari S, Bruscino N, Tripo L. Paradoxical effect of infliximab in a patient with hidradenitis suppurativa. Dermatol Ther. 2012 Jul Aug;25(4):3768. [PMID: 22950564]
141. Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Ashida T, Kohgo Y, Iizuka H. Psoriasiform and pustular eruption induced by infliximab. J Dermatol. 2007 Jul;34(7):468-72. [PMID: 17584325]
142. Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat. 2009;20(2):100-8. [PMID: 18923992]
143. McGovern TW, Erickson AR, Fitzpatrick JE. Sjögren's syndrome plasma cell panniculitis and hidradenitis. J Cutan Pathol. 1996 Apr;23(2):1704. [PMID: 8721452]
144. Marquardt AL, Hackshaw KV. Reactive arthritis associated with hidradenitis suppurativa. J Natl Med Assoc. 2009 Apr;101(4):367-9. [PMID: 19397229]
145. Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Abou El-Saoud AM. Variation of matrix metalloproteinase 1 an 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis. Genet Test Mol Biomarkers. 2012 Jan;16(1):15-20. [PMID: 21770773]
146. Milicic A, Lee D, Brown MA, Darke C, Wordsworth BP. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allel associations in UK Caucasians. J Rheumatol. 2002 Sep;29(9):1821-6. [PMID: 12233873]
147. Nijhawan PK, Elkin PL. 59-year-old man with right hip pain. Mayo Clin Proc. 1998 Jun;73(6):541-4. [PMID: 9621863]
148. Leitch DN, Holland CD, Langtry JA. Hidradenitis suppurativa and monoarthritis of the hip. Clin Exp Dermatol. 1997 Jul;22(4):2067. [PMID: 9499617]
149. Fioravanti A, Lauraflori M, Guidelli GM, Giordano N. Dactylitis as a first manifestation of arthritis associated with hidradenitis suppurativa. Indian J Dermatol Venereol Leprol. 2011 Jan Feb;77(1):746. [PMID: 21220890]
150. Hamoir XL, François RJ, Van den Haute V, Van Campenhoudt M. Arthritis and hidradenitis suppurativa diagnosed i a 48-year-old man. Skeletal Radiol. 1999 Aug;28(8):4536. [PMID: 10486014]
151. Bhalla R, Sequeira W. Arthritis associated with hidradenitis suppurativa. Ann Rheum Dis. 1994 Jan;53(1):646. [PMID: 8311560]
152. Cohen J. Arthritis occurring with hidradenitis suppurativa. J Rheumatol. 1985 Dec;12(6):12089. [PMID: 4093936]
153. Kenik J, Hurley J. Arthritis occurring with hidradenitis suppurativa. J Rheumatol. 1985 Feb;12(1):1834. [PMID: 3981509]
154. Scheinfeld N. Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab. J Am Aca Dermatol. 2006 Jul;55(1):1634. [PMID: 16781316]
155. van Rappard DC, Mooij JE, Baeten DL, Mekkes JR. New onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab. Br J Dermatol. 2011 Jul;165(1):1948. [PMID: 21428974]
156. Marquardt AL, Hackshaw KV. Reactive arthritis associated with hidradenitis suppurativa. J Natl Med Assoc. 2009 Apr;101(4):3679. [PMID: 19397229]
157. Alba D, Torres E, Ripoll MM, Molina F. Reactive arthritis and hidradenitis suppurativa. An Med Interna. 1995 Sep;12(9):4645. [PMID: 8924559]
158. Tallo R, Quinet R, Waxman J. Reactive arthritis due to hidradenitis suppurativa mimicking osteomyelitis. South Med J. 1991 Sep;84(9):11479. [PMID: 1891742]
159. Dixit R, George R, Jacob M, Sudarsanam TD, Danda D. Dowling-Degos disease, hidradenitis suppurativa and arthritis in mother and daughter. Clin Exp Dermatol. 2006 May;31(3):4546. [PMID: 16681601]
160. Coleman, WP. Hidradenitis Suppurativa pp 481-484 in Cutaneous Medicine and Surgery. WB Saunders Company. Philadelphia 1996.
161. Bennett RE, Wilke WS, Murphy DP. Spondyloarthropathy and hidradenitis suppurativa. Ann Intern Med. 1983 Jan;98(1):112. [PMID: 6848034]
162. Ramasastry SS, Granick MS, Boyd JB, Futrell JW. Severe perifolliculitis capitis with osteomyelitis. Ann Plast Surg 1987;18(3):241-4.
163. Maintz L, Betz RC, Allam JP, Wenzel J, Jaksche A, Friedrichs N, Bieber T, Novak N. Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur J Dermatol. 2005 Sep Oct;15(5):34-752. [PMID: 16172043]
164. Hellmann DB. Spondyloarthropathy with hidradenitis suppurativa. JAMA. 1992 May 6;267(17):23635. [PMID: 1564778]
165. Kahn MF, Bouvier M, Palazzo E, Tebib JG, Colson F. Sternoclavicular pustulotic osteitis (SAPHO). 20-year interval between skin and bone lesions. J Rheumatol. 1991 Jul;18(7):1104-8. [PMID: 1920317]
166. Kahn MF, Chamot AM.SAPHO syndrome. Rheum Dis Clin North Am. 1992 Feb;18(1):225-46. [PMID: 1532859]
167. De Souza A, Solomon GE, Strober BE. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. Bull NYU Hosp Jt Dis. 2011;69(2):1857. [PMID: 22035400]
168. Azevedo VF, Dal Pizzol VI, Lopes H, Coelho SP, Czeczko LE. Methotrexate to treat SAPHO syndrome with keloid scars. Acta Reumatol Port. 2011 AprJun;36(2):16770. [PMID: 21841736]
169. Ozyemisci D, Taskiran O, Bölükbasi N, Gögüs F. A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria. Clin Rheumatol. 2007 May;26(5):78991. [PMID: 16680392]
170. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive. J Am Acad Dermatol. 2009 Apr;60(4):539-61; [PMID: 19293006]
171. Queiro R, Moreno P, Sarasqueta C, Alperi M, Riestra JL, Ballina J. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin Exp Rheumatol. 2008 Jan-Feb;26(1):125-8. [PMID: 18328159]
172. Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. Curr Opin Rheumatol. 1993 Jul;5(4):428-35. [PMID: 8357739]
173. Soyfoo MS, Gangji V, Margaux J. Successful treatment of SAPHO syndrome with ibandronate. J Clin Rheumatol. 2010 Aug;16(5):253. [PMID: 20661079]
174. Ichikawa J, Sato E, Haro H, Ando T, Maekawa S, Hamada Y. Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int. 2009 Apr;29(6):713-5. [PMID: 18998139]
175. Bergeron JR, Stone OJ. Interstitial keratitis associated with hidradenitis suppurativa. Arch Dermatol. 1967 May;95(5):4735. [PMID: 4164818]
176. Blanco R, González Vela MC, González López MA, Fernández, Llaca H, Cañal J, González Gay MA. Interstitial keratitis secondary to severe hidradenitis suppurativa responding to adalimumab. Cornea. 2012 Feb;31(2):206; author reply 206. [PMID: 22146546]
177. Meskin SW, Carlson EM. Mooren's type ulceration associated with severe hidradenitis suppurativa: a case report and literature. Ocul Immunol Inflamm. 2011 Oct;19(5):3402. [PMID: 21823931]
178. Alzaga Fernandez AG, Demirci H, DarnleyFisch DA, Steen DW. Interstitial keratitis secondary to severe hidradeniti suppurativa: a case report and literature. Cornea. 2010 Oct;29(10):118991. [PMID: 20628295]
179. Abid N, Opran A, Rosner F. Hidradenitis suppurativa complicated by erosive arthropathy and ulcerative keratitis. J Clin Rheumatol. 1999 Feb;5(1):2931. [PMID: 19078346]
180. Sachs DD, Gordon AT. Hidradenitis suppurativa of glands of Moll. Arch Ophthalmol. 1967 May;77(5):635-6. [PMID: 6022733]
181. Abdollahi A, Hallaji Z, Esmaili N, Valikhani M, Barzegari M, Akhyani M, Toosi S, Miresmaili A. KID syndrome. Dermatol Online J. 2007 Oct 13;13(4):11. [PMID: 18319008]
182. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynänen M, Jabs EW, Bale SJ, DiGiovanna JJ, Uitto J, Russell L. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. 2002 May;70(5):1341-8. [PMID: 11912510]
183. Jan AY, Amin S, Ratajczak P, Richard G, Sybert VP. Genetic heterogeneity of KID syndrome: identification of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia. J Invest Dermatol. 2004 May;122(5):1108-13. [PMID: 15140211]
184. Lazic T, Horii KA, Richard G, Wasserman DI, Antaya RJ. A report of GJB2 (N14K) Connexin 26 mutation in two patients--a new subtype of KID syndrome? Pediatr Dermatol. 2008 Sep-Oct;25(5):535-40. [PMID: 18950394]
185. de Zwart-Storm EA, Hamm H, Stoevesandt J, Steijlen PM, Martin PE, van Geel M, van Steensel MA. A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness. Med Genet. 2008 Mar;45(3):161-6. [PMID: 17993581]
186. Yotsumoto S, Hashiguchi T, Chen X, Ohtake N, Tomitaka A, Akamatsu H, Matsunaga K, Shiraishi S, Miura H, Adachi J, Kanzaki T Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichthyosis-deafness syndrome. Br J Dermatol. 2003 Apr;148(4):649-53. [PMID: 12752120]
187. Bondeson ML, Nyström AM, Gunnarsson U, Vahlquist A. Connexin 26 (GJB2) mutations in two Swedish patients with atypical Vohwinkel (mutilating keratoderma plus deafness) and KID syndrome both extensively treated with acitretin. Acta Derm Venereol. 2006;86(6):503-8. [PMID: 17106596]
188. Arndt S, Aschendorff A, Schild C, Beck R, Maier W, Laszig R, Birkenhäger R. A novel dominant and a de novo mutation in the GJB2 gene (connexin-26) cause keratitis-ichthyosis-deafness syndrome: implication for cochlear implantation. Otol Neurotol. 2010 Feb;31(2):210-5. [PMID: 20101161]
189. Koppelhus U, Tranebjaerg L, Esberg G, Ramsing M, Lodahl M, Rendtorff ND, Olesen HV, Sommerlund M. A nove mutation in the connexin 26 gene (GJB2) in a child with clinical and histological features of keratitis-ichthyosis-deafness (KID) syndrome. Clin Exp Dermatol. 2011 Mar;36(2):142-8. [PMID: 20846357]
190. Jonard L, Feldmann D, Parsy C, Freitag S, Sinico M, Koval C, Grati M, Couderc R, Denoyelle F, Bodemer C, Marli S, Hadj-Rabia S. A familial case of Keratitis-Ichthyosis-Deafness (KID) syndrome with the GJB2 mutation G45E. Eur J Med Genet. 2008 Jan-Feb;51(1):35-43. [PMID: 18024254]
191. Lazic T, Li Q, Frank M, Uitto J, Zhou LH. Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings. Pediatr Dermatol. 2001 May-Jun;29(3):34957. [PMID: 22011219]
192. Wenghoefer M, Allam JP, Novak N, Maintz L, Martini M, Bergé S. Surgical therapy in a patient with Keratosis-Ichthyosis-Deafness (KID) syndrome associated with follicular occlusion triad. Eur J Dermatol. 2007 Sep Oct;17(5):44950. [PMID: 17673397]
193. Sais G, Admella C, Fantova MJ, Montero JC. Lymphocytic autoimmune hidradenitis, cutaneous leucocytoclastic vasculitis and primary Sjögren's syndrome. Br J Dermatol. 1998 Dec;139(6):10736. [PMID: 9990376]
194. Kobayashi I, Furuta H, Tame A, Kawamura N, Kojima K, Endoh M, Okano M, Sakiyama Y. Complications of childhood Sjögren syndrome. Eur J Pediatr. 1996 Oct;155(10):8904. [PMID: 8891560]
195. Ah-Weng A, Langtry JA, Velangi S, Evans CD, Douglas WS. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol. 2005 Nov;30(6):669-71. [PMID: 16197385]
196. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341:1284-1291. [PMID: 10528040]
197. Hatemi G, Yazici H. Behçet's syndrome and micro-organisms. Best Pract Res Clin Rheumatol. 2011 Jun;25(3):389-406. [PMID: 22100288]
198. Deitch HR, Huppert J, Adams Hillard PJ. Unusual vulvar ulcerations in young adolescent females. J Pediatr Adolesc Gynecol. 2004 Feb;17(1):13-6. [PMID: 15010033]
199. Sahin MT, Oztürkcan S, Türel-Ermertcan A, YurtmanHavlucu D, Bilaç C. Behçet's disease associated with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2007 Mar;21(3):428-9. [PMID: 17309492]
200. Hruz P, Eckmann L. Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn's disease. Swiss Med Wkly. 2010 Dec 27; [PMID: 21213148]
201. Billmann-Born S, Lipinski S, Böck J, Till A, Rosenstiel P, Schreiber S. The complex interplay of NOD-like receptor and the autophagy machinery in the pathophysiology of Crohn disease. Eur J Cell Biol. 2011 Jun-Jul;90(6-7):593-602. 2010 Dec 10. [PMID: 21146253]
202. Nassar D, Hugot JP, Wolkenstein P, Revuz J. Lack of association between CARD15 gene polymorphisms and hidradenitis suppurativa: a pilot study. Dermatology. 2007;215(4):359. [PMID: 17911997]
203. Scheinfeld NS, Teplitz E, McClain SA. Crohn's disease and lichen nitidus: a case report and comparison of common histopathologic features. Inflamm Bowel Dis. 2001 Nov;7(4):314-8. [PMID: 11720321]
204. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradeniti suppurativa and perianal Crohn's disease. Int J Colorectal Dis. 1993 Sep;8(3):117-9. [PMID: 8245664]
205. Burrows NP, Jones RR. Crohn's disease in association with hidradenitis suppurativa. Br J Dermatol. 1992 May;126(5):523. [PMID: 1610696]
206. van der Zee HH, van der Woude CJ, Florencia EF, Prens EP. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol. 2010 Jan;162(1):195-7. [PMID: 19681876]
207. Gregor B, Jean R, James J. Hidradenitis suppurativa and Crohn's disease. In: Philippe S, Jean F, Anne C, Jacques C eds. Hidradenitis Suppurativa. 1st ed. New York: Springer; 2006: 50-57.
208. Rerknimitr R, Chalapipat O, Kongkam P, Mb PK. Clinical characteristics of inflammatory bowel disease in Thailand a 16 years review. J Med Assoc Thai. 2005 Sep;88 Suppl 4:S129-33. [PMID: 16623017]
209. Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, Ding Y, Luo H, Hou W, Zhao Q, Liu N, Ren H, Hou X, Xu H.Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis. 2006 Mar;12(3):212-7. [PMID: 16534423]
210. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979 Oct;77(4 Pt 2):914-20. [PMID: 467943]
211. W. Allan Walker and Peter R. Durie. Pediatric gastrointestinal disease: pathophysiology, diagnosis, management, Volume 793. Richard Hamilton Walker BC Decker, 2004 Philadelphia.
212. Stein JM, Lammert F, Zimmer V, Granzow M, Reichert S, Schulz S, Ocklenburg C, Conrads G. Clinical periodontal and microbiologic parameters in patients with Crohn's disease with consideration of the CARD15 genotype. J Periodontol. 2010 Apr;81(4):535-45. [PMID: 20373538]
213. Tsianos EV, Katsanos KH, Tsianos VE. Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol. 2012 Jan 14;18(2):105-18. [PMID: 22253516]
214. Yazdanyar S, Miller IM, Jemec GB. Hidradenitis suppurativa and Crohn's disease: two cases that support an association. Acta Dermatovenerol Alp Panonica Adriat. 2010 Oct;19(3):23-25. [PMID: 20976417]
215. Lebwohl B, Sapadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2003 Nov;49(5 Suppl):S275-6. [PMID: 14576652]
216. Fernando M, Pilar N, Salvador B. Hidradenitis suppurativa and Crohn's disease response to treatment with infliximab. Inflamm Bowel Dis. 2001; 7: 323-326.
217. Katsanos KH, Christodoulou DK, Tsianos EV. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient. Am J Gastroenterol. 2002 Aug;97(8):2155-6. [PMID: 12190206]
218. Rosi YL, Lowe L, Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatolog Treat. 2005 Feb;16(1):58-61. [PMID: 15897171]
219. Savaşan S, El-Baba M. First episode of axillary acne inversa in a teenager on infliximab therapy for Crohn disease. J Pediatr Gastroenterol Nutr. 2013 Jan;56(1):e2-3. [PMID: 22197950]
220. Martínez F, Nos P, Benlloch S, Ponce J. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm Bowel Dis. 2001 Nov;7(4):323-6. [PMID: 11720323]
221. dos Santos CH, Netto PO, Kawaguchi KY, Parreira Alves JA, de Alencar Souza VP, Reverdito S. Association and management of Crohn's disease plus hidradenitis suppurativa. Inflamm Bowel Dis. 2012 Apr;18(4):E801-2 [PMID: 21993924]
222. Elkjaer M, Dinesen L, Benazzato L, Rodriguez J, Løgager V, Munkholm P. Efficacy of Infliximab treatment in patients with severe Fistulizing Hidradenitis Suppurativa. J Crohns Colitis. 2008 Sep;2(3):241-5. [PMID: 21172218]
223. Goischke HK, Ochsendorf FR. Acne inversa in Crohn's disease. Z Gastroenterol. 2001 Nov;39(11):965-9. [PMID: 11778156]
224. Poulin Y. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept. J Cutan Med Surg. 2009 Jul-Aug;13(4):221-5. [PMID: 1970623]
225. Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF-a therapies. J Cutan Med Surg. 2005 Dec;9(6):296-302. [PMID: 16699906]
226. Karampetsou MP, Liossis SN, Sfikakis PP. TNF-α antagonists beyond approved indications: stories of success and prospects for the future. QJM. 2010 Dec;103(12):917-28. [PMID: 20802008]
227. Bleiziffer O, Dragu A, Kneser U, Horch RE. Solving acne inversa (hidradenitis suppurativa) in Crohn disease with buried chip skin grafts. J Cutan Med Surg. 2009 May-Jun;13(3):164-8. [PMID: 19426627]
228. Tsianos EV, Dalekos GN, Tzermias C, Merkouropoulos M, Hatzis J. Hidradenitis suppurativa in Crohn's disease. A further support to this association. J Clin Gastroenterol. 1995 Mar;20(2):151-3. [PMID: 7769199]
229. Goertz RS, Konturek PC, Naegel A, Janka R, Amann K, Maennlein G, Wein A, Hahn EG, Boxberger F. Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease. Med Sci Monit. 2009 Jan;15(1):CS14-CS18. [PMID: 19114971]
230. Koilakou S, Karapiperis D, Tzathas C. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease. Am J Gastroenterol. 2010 Jan;105(1):231-2. [PMID: 20054324]
231. Moschella SL. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases. Int J Dermatol. 2007 Dec;46(12):1287-91. [PMID: 18173525]
232. Roussomoustakaki M, Dimoulios P, Chatzicostas C, Kritikos HD, Romanos J, Panayiotides JG, Kouroumalis EA. Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to antiTNF therapy. J Gastroenterol. 2003;38(10):10004. [PMID: 14614610]
233. Attanoos RL, Appleton MA, Hughes LE, Ansell ID, Douglas-Jones AG, Williams GT. Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease. Histopathology. 1993 Aug;23(2):111-5. [PMID: 8406382]
234. Roy MK, Appleton MA, Delicata RJ, Sharma AK, Williams GT, Carey PD. Probable association between hidradenitis suppurativa and Crohn's disease: significance of epithelioid granuloma. Br J Surg. 1997 Mar;84(3):375-6. [PMID 9117312]
235. Gower-Rousseau C, Maunoury V, Colombel JF, Coulom P, Piette F, Cortot A, Paris JC. Hidradenitis suppurativa an Crohn's disease in two families: a significant association? Am J Gastroenterol. 1992 Jul;87(7):928. [PMID: 1615957]
236. Ostlere LS, Langtry JA, Mortimer PS, Staughton RC. Hidradenitis suppurativa in Crohn's disease. Br J Dermatol. 1991 Oct;125(4):384-6. [PMID: 1954129]
237. McKinney A, Wallace JA, Alderdice JM. Crohn's disease of the labia minora. Ulster Med J. 1995 Apr;64(1):92-94.
238. Canpolat F, Cemil BÇ, Yilmazer D, Yeşilli O, Eskioǧlu F. Pyoderma vegetans associated with ulcerative colitis: a case with good response to steroids. Case Rep Dermatol. 2011 Mar 26;3(1):80-4. [PMID: 21503165]
239. Delaporte E, Viget N, Pasturel-Michon U, Catteau B, Hachulla E, Piette F. Pyostomatitis-pyodermatitis vegetans uncovering a case of Crohn disease. Ann Dermatol Venereol. 1998 May;125(5):331-334. [PMID: 9747282]
240. Lobkowicz F, Eckert F, BraunFalco O. Pyostomatitis vegetans. A specific marker of Crohn disease and ulcerative colitis. Hautarzt. 1991 Feb;42(2):92-5. [PMID: 2037493]
241. Hansen LS, Silverman S Jr, Daniels TE. The differential diagnosis of pyostomatitis vegetans and its relation to bowe disease. Oral Surg Oral Med Oral Pathol. 1983 Apr;55(4):363-73. [PMID: 6574415]
242. Li M, Hunt MJ, Commens CA. Hidradenitis suppurativa, Dowling Degos disease and perianal squamous cell carcinoma. Australas J Dermatol. 1997 Nov;38(4):209-11. [PMID: 9431718]
243. Barth JH, Ng LL, Wojnarowska F, Dawber RP. Acanthosis nigricans, insulin resistance and cutaneous virilism. Br J Dermatol. 1988 May;118(5):613-9. [PMID 3293647]
244. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnely G, Grob JJ, Bastuji-Garin S. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008 Oct;59(4):596-601. [PMID: 18674845]
245. Comorbidities are common among patients with moderate-to-severe hidradenitis suppurativa; depression and morbid obesity are positively associated with disease severity Jeffrey J. Crowley, MD, Bakersfield Dermatology, Bakersfield, CA, United States; Jan Mekkes, MD, PhD, University of Amsterdam, Amsterdam, Netherlands; Martin M. Okun, MD, PhD, Abbott Laboratories, Abbott Park, IL, United States; YihuaGu, MS, Abbott Laboratories, Abbott Park, IL, United States Journal of the American Academy of Dermatology Vol. 68, Issue 4, P6459 Supplement 1, Page AB46. http://download.journals.elsevierhealth.com/pdfs/journals/0190-9622/PIIS0190962212014727.pdf
246. Brown SC, Kazzazi N, Lord PH.Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form. Br J Surg. 1986 Dec;73(12):978-80. [PMID: 3790962]
247. Shelley WB, Cahn MM.: The pathogenesis of hidradenitis suppurativa in man; experimental and histologic observations. AMA Arch Derm 72;562-565:1955. [PMID:13268062]
248. Anderson D.K., Perry A.W. Axillary hidradenitis. Arch Surg 110;69-72:1975. [PMID: 1115611]
249. Harrison BJ., Read GF., Hughes L.E.: Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg 75;972-975:1988. [PMID:3219545]
250. Jansen I, Altmeyer P, Plewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol. 2001 Nov;15(6):532-40. [PMID: 11843212]
251. Ringpfeil F. Selected disorders of connective tissue: pseudoxanthoma elasticum, cutis laxa, and lipoid proteinosis. Clin Dermatol. 2005;23:41-6. [PMID: 15708288]
252. Caliskan Y, Yazici H, Kucuk M, Alisir S, Kilicaslan I, Ecder T. Nephrotic syndrome associated with hidradenitis suppurativa. Clin Nephrol. 2005;63:171-2. [PMID: 15730062]
253. Lee E, Kurtz P, Chang A, Swamy RS. The renal failure that vanished. J Hosp Med. 2010 Jul-Aug;5(6):371-2. [PMID 20803679]
254. Titze J, Schneider M, Krause H, Jacobi J, Stolte M, Linke RP, Rupprecht HD. Diarrhea, nephrotic syndrome and hidradenitis suppurativa: an unusual case. Nephrol Dial Transpl 2003 Jan;18(1):192-4. [PMID: 12480982]
255. Arnadottir M, Jonsson E, Jonsson J. Inactivity of hidradenitis suppurativa after renal transplantation. Transplantation 2006;82:849. [PMID: 17006336]
256. Melnik BC, Plewig G. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis b evidence from translational biology. Exp Dermatol. 2013 Mar;22(3):172-7. [PMID: 23489419]
257. Anstey A. Gamma-secretase gene mutations link acne inversa (flexural, scarring acne) with Alzheimer's disease. J R Coll Physicians Edinb. 2011 Mar;41(1):29 [PMID: 21365064]
258. Girouard SD, Falk RH, Rennke HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J. 2012;18(1):2. [PMID: 22301039]
259. Montes Romero JA, Callejas Rubio JL, Sánchez Cano D, González Martínez FJ, Navas Parejo A, Ortego Centeno N Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab. Eur J Intern Med. 2008 Oct;19(6):e323. [PMID: 18848164]
260. Ingram JR, Wood M, John B, Butler R, Anstey AV. Absence of pathogenic γ-secretase mutations in a South Wales cohort of familial and sporadic hidradenitis suppurativa (acne inversa). Br J Dermatol. 2012 Sep 26 [PMID: 23013355]
261. Wiltz O, Schoetz DJ Jr, Murray JJ, Roberts PL, Coller JA, Veidenheimer MC. Perianal hidradenitis suppurativa. The Lahey Clinic experience. Dis Colon Rectum. 1990 Sep;33(9):731-4. [PMID: 2390907]
262. O'Loughlin S, Woods R, Kirke PN, Shanahan F, Byrne A, Drury MI. Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients. Arch Dermatol. 1988 Jul;124(7):1043-1046. [PMID: 3260468]
263. Tennant F Jr, Bergeron JR, Stone OJ, Mullins JF. Anemia associated with hidradenitis suppurativa. Arch Dermatol. 1968;98:138-40. [PMID: 5667225]
264. Moschella SL. Hidradenitis suppurativa. Complications resulting in death. JAMA. 1966;198(1):201-3. [PMID: 595317]
265. Berná-Serna JD, Berná-Mestre JD. Mammary fistula could be included in the follicular occlusion tetrad. Eur J Dermatol. 2012 Mar-Apr;22(2):261-2. [PMID: 22377756]
266. Berná-Serna JD, Berná-Mestre JD. Follicular occlusion due to hyperkeratosis: a new hypothesis on the pathogenesis mammillary fistula. Med Hypotheses. 2010 Dec;75(6):553-4. [PMID: 20708341]
267. Cosman BC, Al-Refaie WB. Mammillary fistula as a manifestation of acne inversa (hidradenitis suppurativa): report of two cases. J Am Coll Surg. 2002 Jun;194(6):829-33. [PMID: 12081074]
268. Kelleher RJ, Shen J. Genetics. Gamma-secretase and human disease. Science. 2010;330(6007): [PMID: 21097925]
269. Wang B, Yang W, Wen W, Sun J, Su B, Liu B, Ma D, Lv D, Wen Y, Qu T, Chen M, Sun M, Shen Y, Zhang X. Gamma-secretase gene mutations in familial acne inversa. Science. 2010;330(6007):1065. [PMID: 20929727]
270. Gao M, Wang PG, Cui Y, Yang S, Zhang YH, Lin D, Zhang KY, Liang YH, Sun LD, Yan KL, Xiao FL, Huang W, Zhang XJ. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol. 2006 Jun;126(6):1302-6. [PMID: 16543891]
271. Zimmermann CC, Sforza D, Macedo PM, Azulay-Abulafia L, Alves Mde F, Carneiro SC. Dowling-Degos disease: classic clinical and histopathological presentation. An Bras Dermatol. 2011 Sep-Oct;86(5):979-82. [PMID: 22147038]
272. Loo WJ, Rytina E, Todd PM. Hidradenitis suppurativa, Dowling Degos and multiple epidermal cysts: a new follicula occlusion triad. Clin Exp Dermatol. 2004 Nov;29(6):6224. [PMID: 15550138]
273. Kleeman D, Trüeb RM, Schmid-Grendelmeier P. Reticular pigmented anomaly of the flexures. Dowling-Degos disease of the intertrigo type in association with acne inversa. Hautarzt. 2001 Jul;52(7):642-5. [PMID: 11475647]
274. Bedlow AJ, Mortimer PS. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol. 1999 Jul;21(4):305-6. [PMID: 8959907]
275. Balus L, Fazio M, Amantea A, Menaguale G. Dowling-Degos disease and Verneuil disease. Ann Dermatol Venereol 1993;120(10):705-8. [PMID: 8161103]
276. Fenske NA, Groover CE, Lober CW, Espinoza CG. Dowling-Degos disease, hidradenitis suppurativa, and multiple keratoacanthomas. A disorder that may be caused by a single underlying defect in pilosebaceous epithelial proliferation. J Am Acad Dermatol. 1991 May;24(5 Pt 2):888-92. [PMID: 2050858]
277. Weber LA, Kantor GR, Bergfeld WF. Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a cas report associated with hidradenitis suppurativa and squamous cell carcinoma. Cutis. 1990 Jun;45(6):446-50. [PMID: 235098]
278. Lookingbill DP. Yield from a complete skin examination. Findings in 1157 new dermatology patients. J Am Acad Dermatol 1988;18;31-37. [PMID: 3346406]
279. Ujihara M, Kamakura T, Ikeda M, Kodama H. Dowling-Degos disease associated with squamous cell carcinomas on the dappled pigmentation. Br J Dermatol. 2002 Sep;147(3):568-71. [PMID: 12207603]
280. Marzano AV, Ishak RS, Colombo A, Caroli F, Crosti C. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology. 2012;225(3):2159. [PMID: 23171584]
281. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012 Mar;66(3):40915. [PMID: 21745697]
282. Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS. Hidradenitis suppurativa and concomitant pyoderm gangrenosum: a case series and literature review. Arch Dermatol. 2010 Nov;146(11):1265-70. [PMID: 21079064]
283. García-Rabasco AE, Esteve-Martínez A, Zaragoza-Ninet V, Sánchez-Carazo JL, Alegre-de-Miquel V. Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature. Actas Dermosifiliogr. 2010 Oct;101(8):717-21. [PMID: 20965015]
284. Reddick CL, Singh MN, Chalmers RJ. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab. Dermatol Online J. 2010 Aug 15;16(8):15. [PMID: 20804692]
285. Bruzzese V. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of antitumor necrosis factor α therapy. J Clin Rheumatol. 2012 Dec;18(8):4135. [PMID: 23188209]
286. Raynor A, Askari AD. Behçet's disease and treatment with colchicine. J Am Acad Dermatol. 1980 May;2(5):396-40 [PMID: 7381068]
287. Plewig G, Wolff HH, Braun-Falco O. Steatocystoma multiplex: anatomic reevaluation, electron microscopy, and autoradiography. Arch Dermatol Res. 1982;272(3/4):363-80. [PMID: 7165345]
288. McDonald RM, Reed WB. Natal teeth and steatocystoma multiplex complicated by hidradenitis suppurativa. A new syndrome. Arch Dermatol. 1976 Aug;112(8):1132-4. [PMID: 988984]
289. Hollmig T, Menter A. Familial coincidence of hidradenitis suppurativa and steatocystoma multiplex. Clin Exp Dermatol. 2010 Jun;35(4):e151-2. [PMID: 19886955]
290. Wan JM, Wong JS, Tee SI. Mammographic and sonographic findings of steatocystoma multiplex presenting as breas lumps. Singapore Med J. 2012 Dec;53(12):e261-3. [PMID: 23268169]
291. Gollhausen R, Besenhard HM, Ruzicka T. Steatocystoma multiplex conglobatum. Hautarzt. 1988 Mar;39(3):1779. [PMID: 3378891]
292. Marinella MA. Lithium therapy associated with hidradenitis suppurativa. Acta Derm Venereol. 1997 Nov;77(6):483. [PMID: 9394991]
293. Gupta AK, Knowles SR, Gupta MA, Jaunkalns R, Shear NH.Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol. 1995 Feb;32(2 Pt 2):382-6. [PMID: 7829746]
294. Mahé E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF, Mamzer-Bruneel MF, de Prost Y, Kreis H, Bodemer C. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005 Feb 27;79(4):476-82. [PMID: 15729175]
295. Mahé E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF, Mamzer-Bruneel MF, de Prost Y, Kreis H, Bodemer C. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005 Feb 27;79(4):476-82. [PMID: 15729175]
296. Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med. 1984 Oct;77(4):652-6. [PMID: 6486141]
297. Ma L, Dominguez AR, Collins GR, Kia KF, Cockerell CJ. Hidradenitis Suppurativa, Eruptive Melanocytic Nevi, an Keratosis Pilaris-like Eruption in a Patient Treated With Vemurafenib. Arch Dermatol. 2012;148:14289. [PMID: 23247496]
298. Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ. 1989 Jan 7;298(6665):28-9. [PMID: 2492847]
299. Feinstein A., Friedman J., Schewach-Millet M. Pachyonychia congenita. J Am Acad Dermatol 1988 Oct;19:705-711 [PMID:3053803]
300. Todd P., Garioch J., Rademaker M., Susskind W., Gemell C., Thomson J. Pachyonychia congenita complicated by hidradenitis suppurativa: a family study. Br J Dermatol. 1990;123: 663-666. [PMID: 2248894]
301. Pedraz J, Peñas PF, Garcia-Diez A. Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy. J Eur Acad Dermatol Venereol. 2008 Dec;22(12):1500-1. [PMID: 18482325]
302. Smith FJ, Corden LD, Rugg EL, Ratnavel R, Leigh IM, Moss C, et al. Missense mutations in keratin 17 cause either Pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol. 1997;108:220-223. [PMID:9008238]
303. Oh SW, Kim MY, Lee JS, Kim SC. Keratin 17 mutation in Pachyonychia congenita type 2 patient with early onset steatocystoma multiplex and Hutchinson-like tooth deformity. J Dermatol. 2006;33:161-164. [PMID: 16620218]
304. Bergeron JR, Stone OJ. Follicular occlusion triad in a follicular blocking disease (pityriasis rubra pilaris). Dermatologica. 1968;136(5):362-7 [PMID: 4232636]
305. Asgeirsson T, Nunoo R, Luchtefeld MA. Hidradenitis suppurativa and pruritus ani. Clin Colon Rectal Surg. 2011 Mar;24(1):7180. [PMID: 22379408]
306. Moroz A, Lee MH, Clark J. Reflex sympathetic dystrophy with hidradenitis suppurativa exacerbation: a case report. Arch Phys Med Rehabil. 2001 Mar;82(3):412-4. [PMID: 11245766]
307. Yung A, Newton-Bishop JA. A case of Bazex-Dupré-Christol syndrome associated with multiple genital trichoepitheliomas. Br J Dermatol. 2005 Sep;153(3):682-4. [PMID:16120174]
308. Borbujo Martínez J, Bastos Amigo J, Olmos Carrasco O, San José Hugenot I, Toribio Dapena R, Casado Jímenez M Suppurative hidradenitis in Down's syndrome. Apropos of three cases. An Esp Pediatr. 1992;36:59-61.
309. Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7(2):e31810. [PMID: 22359634]
310. Join-Lambert O, Fraitag S, Ribadeau-Dumas F, Leguern AS, Behillil S, Del Castillo FJ, Consigny PH, Auquier F, Eb F, Sevestre H, Lortholary O, Nassif X, Nassif A. Is granulomatous mastiti a localized form of hidradenitis suppurativa? Eur J Dermatol. 2009 Sep-Oct;19(5):513-4. [PMID: 19527995]
311. Matusiak L, Bieniek A, Szepietowski JC. Soluble interleukin-2 receptor serum level is a useful marker of hidradeniti suppurativa clinical staging. Biomarkers. 2009 Sep;14(6):432-7. [PMID: 19627253]